Sec. 1. Short title; table of contents
710 words·~3 min read·
/bill/116/hr/3/eh/section-1A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
This Act may be cited as the . Elijah E. Cummings Lower Drug Costs Now Act The table of contents is as follows: Sec. 1. Short title; table of contents. Title I—Lowering Prices Through Fair Drug Price Negotiation Sec. 101. Providing for lower prices for certain high-priced single source drugs. Sec. 102. Selected drug manufacturer excise tax imposed during noncompliance periods. Sec. 103. Fair Price Negotiation Implementation Fund. Title II—Medicare Parts B and D Prescription Drug Inflation Rebates Sec. 201.
Medicare part B rebate by manufacturers. Sec. 202. Medicare part D rebate by manufacturers. Sec. 203. Provision regarding inflation rebates for group health plans and group health insurance coverage. Sec. 204. Annual report on drug costs in group health plans and group health insurance coverage. Sec. 205. Collection of data. Title III—Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries Sec. 301. Medicare part D benefit redesign. Sec. 302. Allowing certain enrollees of prescription drugs plans and MA–PD plans under Medicare program to spread out cost-sharing under certain circumstances.
Sec. 303. Establishment of pharmacy quality measures under Medicare part D. Title IV—Drug Price Transparency Sec. 401. Drug price transparency. Title V—Program improvements for Medicare low-income beneficiaries Sec. 501. Dissemination to Medicare part D subsidy eligible individuals of information comparing premiums of certain prescription drug plans. Sec. 502. Providing for intelligent assignment of certain subsidy eligible individuals auto-enrolled under Medicare prescription drug plans and MA–PD plans.
Sec. 503. Expanding eligibility for low-income subsidies under part D of the Medicare program. Sec. 504. Automatic eligibility of certain low-income territorial residents for premium and cost-sharing subsidies under the Medicare program; Sunset of enhanced allotment program. Sec. 505. Automatic qualification of certain Medicaid beneficiaries for premium and cost-sharing subsidies under part D of the Medicare program. Sec. 506. Providing for certain rules regarding the treatment of eligible retirement plans in determining the eligibility of individuals for premium and cost-sharing subsidies under part D of the Medicare program.
Sec. 507. Reducing cost-sharing and other program improvements for low-income beneficiaries. Title VI—Providing for Dental, Vision, and Hearing Coverage under the Medicare program Sec. 601. Dental and oral health care. Sec. 602. Providing coverage for hearing care under the Medicare program. Sec. 603. Providing coverage for vision care under the Medicare program. Title VII—NIH, FDA, and Opioids Funding Subtitle A—Biomedical Innovation Expansion Sec. 701. NIH Innovation Initiatives.
Sec. 702. NIH clinical trial. Sec. 703. Innovation Network. Subtitle B—Investing in Safety and Innovation Sec. 711. Food and Drug Administration. Sec. 712. Study on high-risk, high-reward drugs. Subtitle C—Opioid Epidemic Response Sec. 721. Opioid Epidemic Response Fund. Sec. 722. Substance Abuse and Mental Health Services Administration. Sec. 723. Centers for Disease Control and Prevention. Sec. 724. Food and Drug Administration. Sec. 725. National Institutes of Health. Sec. 726.
Health Resources and Services Administration. Sec. 727. Administration for Children and Families. Subtitle D—Reducing Administrative Costs and Burdens in Health Care Sec. 731. Reducing administrative costs and burdens in health care. Title VIII—Miscellaneous Sec. 801. Guaranteed issue of certain Medigap policies. Sec. 802. Reporting requirements for PDP sponsors regarding point-of-sale rejections under Medicare part D. Sec. 803. Providing access to annual Medicare notifications in multiple languages.
Sec. 804. Temporary increase in Medicare part B payment for certain biosimilar biological products. Sec. 805. Waiving medicare coinsurance for colorectal cancer screening tests. Sec. 806. Medicare coverage of certain lymphedema compression treatment items. Sec. 807. Physician fee update. Sec. 808. Additional community health center funding. Sec. 809. Grants to improve trauma support services and mental health care for children and youth in educational settings. Sec. 810. Pathway to Health Careers Act.
Sec. 811. Home Visiting to Reduce Maternal Mortality and Morbidity Act. Sec. 812. Addition of new measures based on access to biosimilar biological products to the 5-star rating system under medicare advantage. Sec. 813. Sense of Congress regarding the impact of the high cost of prescription drugs on communities of color and persons living in rural or sparsely populated areas of the United States. Sec. 814. Regulations requiring direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
Sec. 815. Improving transparency and preventing the use of abusive spread pricing and related practices in Medicaid. Sec. 816. Graduate medical education improvements in rural and underserved communities.